Biological markers in obsessive-compulsive and affective disorders.
暂无分享,去创建一个
L. Siever | T. Insel | D. Murphy | J. Gillin | E. Mueller
[1] T. Uhde,et al. New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine. , 1984, Biological psychiatry.
[2] T. Insel,et al. The dexamethasone suppression test: promises and problems of diagnostic laboratory tests in psychiatry. , 1983, Hospital & community psychiatry.
[3] T. Insel,et al. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. , 1983, Archives of general psychiatry.
[4] A. Coppen,et al. Dexamethasone Suppression Test in Depression and other Psychiatric Illness , 1983, British Journal of Psychiatry.
[5] R. Gibbons,et al. Symptom profile of patients with positive DST: a pilot study. , 1983, Biological psychiatry.
[6] J. Gillin. Sleep Studies in Affective Illness: Diagnostic, Therapeutic, and Pathophysiological Implications , 1983 .
[7] B. Carroll,et al. Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. , 1983, Archives of general psychiatry.
[8] S. Z. Langer,et al. Complex Inhibition of [3H]Imipramine Binding by Serotonin and Nontricyclic Serotonin Uptake Blockers , 1983, Journal of neurochemistry.
[9] W. Coryell,et al. Dexamethasone suppression test response in major depression: Stability across hospitalizations , 1983, Psychiatry Research.
[10] D. Kupfer,et al. EEG sleep in outpatients with generalized anxiety: A preliminary comparison with depressed outpatients , 1983, Psychiatry Research.
[11] P. Wood,et al. Normalization of platelet [3H]imipramine binding in depressed patients during remission. , 1982, European journal of pharmacology.
[12] W. Brown,et al. Pituitary-adrenal regulation over multiple depressive episodes , 1982, Psychiatry Research.
[13] J. Nurnberger,et al. Platelet 3H-imipramine binding in euthymic bipolar patients , 1982, Psychiatry Research.
[14] P. Plenge,et al. 3H-imipramine binding sites in platelets from psychiatric patients , 1982, Psychiatry Research.
[15] J. Booth,et al. The dexamethasone suppression test in mania. , 1982, Journal of affective disorders.
[16] S. Gershon,et al. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. , 1982, Science.
[17] F. Holsboer,et al. Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement. , 1982, Journal of affective disorders.
[18] T. Insel. Obsessive compulsive disorder-five clinical questions and a suggested approach. , 1982, Comprehensive psychiatry.
[19] T. Insel,et al. The dexamethasone suppression test in patients with primary obsessive-compulsive disorder , 1982, Psychiatry Research.
[20] V. Reus. Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioral symptoms. , 1982, Biological psychiatry.
[21] D. Charney,et al. Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects. , 1982, Archives of general psychiatry.
[22] J. Amsterdam,et al. The dexamethasone suppression test in outpatients with primary affective disorder and healthy control subjects. , 1982, The American journal of psychiatry.
[23] B. Carroll,et al. EEG studies of sleep in the diagnosis of depression. , 1982, Biological psychiatry.
[24] A. Rush,et al. Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar major depressive disorders. , 1982, Biological psychiatry.
[25] F. Goodwin,et al. Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter". , 1981, Archives of general psychiatry.
[26] M. Briley,et al. Reduced uptake of serotonin but unchanged 3H-imipramine binding in the platelets from cirrhotic patients. , 1981, Life sciences.
[27] T. Insel,et al. The psychopharmacological treatment of obsessive-compulsive disorder: a review. , 1981, Journal of clinical psychopharmacology.
[28] S. Paul,et al. Does high affinity [3H] imipramine binding label serotonin reuptake sites in brain and platelet? , 1981, Life sciences.
[29] M. Palkovits,et al. Regional distribution of [3H]imipramine binding in rat brain , 1981, Brain Research.
[30] S. Checkley,et al. Growth Hormone and other Responses to Clonidine in Patients with Endogenous Depression , 1981, British Journal of Psychiatry.
[31] M. Åsberg,et al. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. , 1980, Archives of general psychiatry.
[32] F. Holsboer,et al. DIAGNOSTIC VALUE OF DEXAMETHASONE SUPPRESSION TEST IN DEPRESSION , 1980, The Lancet.
[33] B. Carroll,et al. Diagnosis of endogenous depression. Comparison of clinical, research and neuroendocrine criteria. , 1980, Journal of affective disorders.
[34] G. Winokur,et al. Hypothalamic-pituitary-adrenal axis activity in depressive illness. Its relationship to classification. , 1980, Archives of general psychiatry.
[35] F. Goodwin,et al. Demonstration of specific high affinity binding sites for [3H] imipramine in human brain. , 1980, Life sciences.
[36] B. Carroll,et al. Normalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression. , 1980, Biological psychiatry.
[37] G. Vogel,et al. Improvement of depression by REM sleep deprivation. New findings and a theory. , 1980, Archives of general psychiatry.
[38] M. Ackenheil,et al. Effect of clonidine on growth hormone release in psychiatric patients and controls , 1980, Psychiatry Research.
[39] J. Gillin,et al. REM architecture changes in bipolar and unipolar depression. , 1979, The American journal of psychiatry.
[40] M. Briley,et al. Human platelets possess high-affinity binding sites for 3H-imipramine. , 1979, European journal of pharmacology.
[41] M. Briley,et al. Specific tricyclic antidepressant binding sites in rat brain , 1979, Nature.
[42] W. Brown,et al. The 24-hour dexamethasone suppression test in a clinical setting: relationship to diagnosis, symptoms, and response to treatment. , 1979, The American journal of psychiatry.
[43] Bhagavan Hn,et al. L-tryptophan in obsessive-compulsive disorders. , 1977 .
[44] D. Kupfer,et al. Electroencephalographic sleep diagnosis of primary depression. , 1976, Archives of general psychiatry.
[45] D J Kupfer,et al. Rapid eye movement sleep density. An objective indicator in severe medical-depressive syndromes. , 1976, Archives of general psychiatry.
[46] D J Kupfer,et al. REM latency: a psychobiologic marker for primary depressive disease. , 1976, Biological psychiatry.
[47] J. Mendels,et al. Sleep of depressed patients in remission. , 1974, Archives of general psychiatry.
[48] D. W. Goodwin,et al. Follow-up studies in obsessional neurosis. , 1969, Archives of general psychiatry.
[49] M. Hamilton,et al. Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.
[50] J. Schildkraut,et al. The catecholamine hypothesis of affective disorders: a review of supporting evidence. , 1965, The American journal of psychiatry.
[51] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[52] Drug Literature Abstracts , 2012, Drugs.
[53] H. Meltzer,et al. SEROTONIN UPTAKE IN BLOOD PLATELETS AS A BIOLOGICAL MARKER FOR MAJOR DEPRESSIVE DISORDERS , 1982 .
[54] B. Carroll,et al. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. , 1981, Archives of general psychiatry.
[55] J. Shih,et al. Decreased 3H-imipramine binding in depressed males and females. , 1980, Communications in psychopharmacology.
[56] J. Gillin,et al. Successful separation of depressed, normal, and insomniac subjects by EEG sleep data. , 1979, Archives of general psychiatry.
[57] D J Kupfer,et al. The application of EEG sleep for the differential diagnosis of affective disorders. , 1978, The American journal of psychiatry.
[58] W. Mendelson,et al. Human Sleep and Its Disorders , 1977, Springer US.